Dorling Janet 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 26, 2024
Insider Transaction Report
Form 4
Dorling Janet
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-24+14,010→ 14,010 totalExercise: $22.85Exp: 2034-01-23→ Common Stock (14,010 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the underlying shares monthly from January 1, 2024.